EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Story of Precision Nanomedicine

Lajos P Balogh

Precision Nanomedicine · 2018

DOI: 10.29016/180328.1 ↗
AbstractBibliografische Angaben

Abstract

The story of the journal "Precision Nanomedicine" started back in December 2015 when the contract of the Editor-in-chief of "Nanomedicine: Nanotechnology, Biology, and Medicine" was not renewed by Elsevier without any justification. While it was fully within the legal rights of the publisher to make that decision, they failed to consult with the NNBM editorial board. Elsevier also rejected a collective letter signed by 74 board members and editors requesting the reversal of the decision and served up the usual excuses. This was not the first instance of a publisher acting without the input of an editorial board or completely disregarding sicentists' opinion [1] [2], [3], and the reaction was also similar. In 2015, almost all associate editors and more than 60 editorial board members of the journal Lingua resigned in protest [3]. Similar to the mutiny by Lingua's editors, we also set out to launch our own open-access journal[2] to promote all progressive and rational aspects of nanomedicine including theory and practice while exercising good publishing practices (for a deeper analysis of the present state of scholarly publishing see the opinion paper in this issue).

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →